Login
|
Register
News
Media
Insights
Peer Exchange
OncNurse TV
Webinars
Podcasts
Resources
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Gynecologic Cancers
Supportive Care
Blood Cancers
Prevention
Genetics
Nurse Navigation
Immuno-Oncology
Drug Safety
Skin Cancer/Melanoma
Brain Cancer
Childhood/AYA Cancer
Head and Neck Cancers
Adverse Event Management
Contributors
Conferences
Partners
Advocacy
Associations
Schools of Nursing
Publications
CE
Register now to learn about a new option for relapsed or refractory follicular lymphoma
Skin Cancer/Melanoma
Precision Medicine Highlights the Importance of Biomarkers in Melanoma
BY ERICA DINAPOLI
Tebentafusp Boosts Survival in Metastatic Uveal Melanoma
BY GINA MAURO
Cemiplimab Is Promising for Metastatic Basal Cell Carcinoma Treatment
BY CAROLINE SEYMOUR
Cabozantinib Plus Pembrolizumab May Improve Melanoma Outcomes
BY GINA MAURO
Predicting Immunotherapy Response in Melanoma
BY DANIELLE TERNYILA
How To Choose Immunotherapy or BRAF-Targeted Treatment for Adjuvant Melanoma
BY GINA MAURO
Personalized Treatments, Overcoming Resistance Is Needed in Melanoma
BY GINA MAURO
Better Disease Biology Is Needed to Improve Melanoma Outcomes
BY ERICA DINAPOLI
Three-Drug Combos May Overcome Targeted Therapy Resistance in Melanoma
BY KRISTI ROSA
When COVID-19 and Cancer Collide: What Nurses Should Know
BY BRIELLE BENYON
Next Page >>
External Resources
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
OncNurse Resources
Newsroom
Continuing Education
Discussions
Web Exclusives
About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.